APA (7th ed.) Citation

K, S., B, M., NK, L., B, T., M, B., XP, H., . . . J, H. (2019). Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer. International journal of cancer, 145(12), 3299. https://doi.org/10.1002/ijc.32481

Chicago Style (17th ed.) Citation

K, Schmitt, et al. "Somatic Mutations and Promotor Methylation of the Ryanodine Receptor 2 Is a Common Event in the Pathogenesis of Head and Neck Cancer." International Journal of Cancer 145, no. 12 (2019): 3299. https://doi.org/10.1002/ijc.32481.

MLA (9th ed.) Citation

K, Schmitt, et al. "Somatic Mutations and Promotor Methylation of the Ryanodine Receptor 2 Is a Common Event in the Pathogenesis of Head and Neck Cancer." International Journal of Cancer, vol. 145, no. 12, 2019, p. 3299, https://doi.org/10.1002/ijc.32481.